Various factors are propelling the blood plasma derivatives market growth. These factors, as per the new MRFR report, include growing demand for plasma derivative-based therapies, increasing incidence of hemophilia, increasing funding for R&D activities, advancements in technology, and growing approval from regulatory bodies. Additional factors propelling market growth include increasing prevalence of life-threatening diseases, including hepatitis and HIV, and various non-government and government organizations conducting and promoting blood donation camps.
The global Blood Plasma Derivatives Market is predicted to touch USD 33,590 million at a 10.1% CAGR over the forecast period (2019-2025), states the new Market Research Future (MRFR) report. Plasma is a fluid portion of the blood which contains protein and blood cells that are responsible for blood clotting. The plasma derivative is obtained from definite plasma proteins through fractionation. Then the derivatives are heat-treated or solvent detergent-treated for killing viruses. Blood plasma helps in maintaining the blood pressure and assist in exchanging of essential minerals such as potassium and sodium for maintaining the body’s pH balance.
The rise in global geriatric population also fuels the growth of the blood plasma derivatives market. The elderly population is generally at more risk of acquiring life-threatening diseases which consequently necessitates treatment and further intensifies the growth of the market.
Other driving factors include raising awareness regarding blood and plasma donation and advancement in the preservation techniques of blood plasma. Also, an outlay of substantial amounts on research & development activities and expanding range of clinical applications of blood plasma derivatives are expected to be a tailwind for the growth of the global blood plasma derivatives market.
- Bain Capital
- Biotest AG
- Octapharma AG
- CSL Limited
- Baxter International Inc
- Fusion Healthcare
- SK Plasma
- The MRFR report provides an all-inclusive segmental analysis of the blood plasma derivatives market report on the basis of type, end user, and application.
- Based on type, the blood plasma derivatives market is segmented into fresh frozen plasma (FFP), intravenous immunoglobulin (IVIG), anti-thrombin, albumin, and others.
- Based on application, the blood plasma derivatives market is segmented into Thrombocytosis, Hepatitis C, Hepatitis B, HIV, Hemophilia B, Hemophilia A, and others. Others include Von Willebrand disease.
- Based on end users, the blood plasma derivatives market is segmented into blood transfusion centers, diagnostic centers, hospitals, and others.
By region, the blood plasma derivatives market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, North America, and the Middle East and Africa. Of these, North America will spearhead the blood plasma derivatives market over the forecast period. It is predicted to grow at a 4.25% CAGR. This region is the largest market for needle and syringe. Awareness about the usage of plasma derivatives for patients with infectious diseases is boosting the market growth in the region.
The blood plasma derivatives market in Europe is predicted to have the second-largest share in the market over the forecast period. It is predicted to grow at a 3.8% CAGR. Factors aiding growth in the region include extensive research on safe blood transfusion in research laboratories and healthcare organizations.
The blood plasma derivatives market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is chiefly due to the burgeoning demand for plasma derivatives for inactivation of HIV. India is the key contributor in this region.
The blood plasma derivatives market in the Middle East and Africa is predicted to have a steady growth over the forecast period.
NOTE : Our team of researchers are studying Covid19 and its impact